• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


6.4700 USD 0.0400 0.62%

As of 20:10:00 ET on 11/21/2014.

Snapshot for Endocyte Inc (ECYT)

Open: 6.5400 Day's Range: 6.3800 - 6.6160 Volume: 786,796
Previous Close: 6.4300 52wk Range: 5.3100 - 33.7000 1-Yr Rtn: -40.09%

Stock Chart for ECYT

No chart data available.
  • ECYT:US 6.4700
  • 1D
  • 1M
  • 1Y
Interactive ECYT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ECYT

Current P/E Ratio (ttm) 21.4388
Estimated P/E(12/2014) 115.5357
Relative P/E vs. SPX 1.1721
Earnings Per Share (USD) (ttm) 0.3018
Est. EPS (USD) (12/2014) 0.0560
Est. PEG Ratio -
Market Cap (M USD) 269.86
Shares Outstanding (M) 41.71
30 Day Average Volume 930,592
Price/Book (mrq) 1.2773
Price/Sale (ttm) 2.8928
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ECYT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ECYT

Endocyte Inc. is a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. The Company uses a proprietary technology to create small molecule drug conjugates, or SMDCs, and companion imaging diagnostics that actively target receptors that are over-expressed on diseased cells, relative to healthy cells.

P Ron EllisPresident/CEO/Co-FounderMichael A ShermanCFO/COO
Philip S LowChief Science OfficerBinh NguyenVP:Medical Affairs
More Company Profile & Key Executives for ECYT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil